When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...
In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo in patients with limited-stage small cell lung cancer ...
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...
Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...
Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...
Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...
The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...
As Ahmet F. Coskun and his team of researchers continue their mission to create a 3D atlas of the human body, mapping cells ...